Grant Support

  • 07-10 Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma, the National Institutes of Health (NIH. 00-CH-0093), Associate Investigator, Tobias Carling
  • 02-04 Genetics, Diagnostics and Treatment of Endocrine Tumors, Co-P.I. Tobias Carling, the Swedish Cancer Foundation, $221,000 annually for 3 years
  • 02-04 Calcium regulation, Genetics and Treatment of Primary Hyperparathyroidism, Co-P.I. Tobias Carling, The Swedish Research Council, $174,430 annually for 3 years
  • 01-02 Molecular Mechanisms of Endocrine Regulated Neoplasia and Involvement of the RIZ Tumor Suppressor in Sex Steroid Hormone Receptor Action. P.I. Tobias Carling, The Swedish Society for Medical Research, $30,000 annually for 2 years
  • 00 Clinical & Genetic Studies of Sporadic Hyperparathyroidism and Pheochromocytoma. P.I. Tobias Carling, The Astrid Karlsson Foundation, Uppsala University. $15,000 for 1 year
  • 00 Clinical and Genetic Studies of Sporadic and Familial Hyperparathyroidism, P.I. Tobias Carling, Fredrik and Ingrid Thuring Foundation, $18,000 for 1 year
  • 98-01 Clinical and Genetic Studies of Hyperparathyroidism, Co-P.I. Tobias Carling, the Swedish Medical Research Council, $90,300 annually for 3 years
  • 98-01 Clinical and Genetic Studies of Endocrine Tumors, Co-P.I. Tobias Carling, the Swedish Cancer Foundation, $150,650 annually for 3 years
  • 99 Clinical and Genetic Studies of Hyperparathyroidism. P.I. Tobias Carling, Svenska Läkarsällskapet, $12,000 for 1 year